115 related articles for article (PubMed ID: 33073637)
1. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis.
Zhu Z; Zhong F
Cancer Invest; 2020 Nov; 38(10):543-548. PubMed ID: 33073637
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database.
Jiang S; Zhao R; Li Y; Han X; Liu Z; Ge W; Dong Y; Han W
Sci Rep; 2018 May; 8(1):7940. PubMed ID: 29786691
[TBL] [Abstract][Full Text] [Related]
4. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
[TBL] [Abstract][Full Text] [Related]
5. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
7. Small Bowel Adenocarcinomas: Impact of Location on Survival.
Lee TC; Wima K; Morris MC; Winer LK; Sussman JJ; Ahmad SA; Wilson GC; Patel SH
J Surg Res; 2020 Aug; 252():116-124. PubMed ID: 32278965
[TBL] [Abstract][Full Text] [Related]
8. What prognostic factors are important in duodenal adenocarcinoma?
Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
10. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.
Struck A; Howard T; Chiorean EG; Clarke JM; Riffenburgh R; Cardenes HR
J Surg Oncol; 2009 Aug; 100(2):144-8. PubMed ID: 19544358
[TBL] [Abstract][Full Text] [Related]
11. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
12. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis.
Thiessen M; Lee-Ying RM; Monzon JG; Tang PA
J Gastrointest Cancer; 2020 Mar; 51(1):280-288. PubMed ID: 31111426
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
[No Abstract] [Full Text] [Related]
14. Neoadjuvant treatment of duodenal adenocarcinoma: a rescue strategy.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Lombardo KM; Haddock MG; Que FG
J Gastrointest Surg; 2012 Feb; 16(2):320-4. PubMed ID: 21956430
[TBL] [Abstract][Full Text] [Related]
15. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis.
Wilhelm A; Galata C; Beutner U; Schmied BM; Warschkow R; Steffen T; Brunner W; Post S; Marti L
J Surg Oncol; 2018 Mar; 117(3):397-408. PubMed ID: 29044591
[TBL] [Abstract][Full Text] [Related]
16. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.
Jang BS; Park HJ; Kim K; Jang JY; Kim SW; Oh DY; Chie EK
World J Surg; 2018 Oct; 42(10):3294-3301. PubMed ID: 29869181
[TBL] [Abstract][Full Text] [Related]
17. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database.
Platoff RM; Kellish AS; Hakim A; Gaughan JP; Atabek UM; Spitz FR; Hong YK
Am Surg; 2021 Feb; 87(2):266-275. PubMed ID: 32927979
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.
Sarela AI; Brennan MF; Karpeh MS; Klimstra D; Conlon KC
Ann Surg Oncol; 2004 Apr; 11(4):380-6. PubMed ID: 15070597
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma.
Chung WC; Paik CN; Jung SH; Lee KM; Kim SW; Chang UI; Yang JM
Korean J Intern Med; 2011 Mar; 26(1):34-40. PubMed ID: 21437160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
